Symbiotec Pharmalab Updates Corporate Identification Number Following Stock Exchange Listing
Symbiotec Pharmalab Ltd · Others (Uncategorized) · 17 Nov 2026, 4:14 pm
Symbiotec Pharmalab Updates Corporate Identification Number Following Stock Exchange Listing Pursuant to listing its equity shares on the BSE and NSE effective 1st Sep'26, Symbiotec Pharmalab Limited received an updated Corporate Identification Number (CIN) from the Registrar of Companies, Gwalior. In Ministry of Corporate Affairs records, the company's CIN transitioned from U24232MP2002PLC015293 to L24232MP2002PLC015293, formally updating its listing status to "Yes". MCA master data reflects an authorized capital of ₹30,00,00,000 and paid-up capital of ₹12,85,12,224.
Original exchange filing (PDF)
More announcements from Symbiotec Pharmalab Ltd
- Transcript of the Earnings conference call for the Analysts and Investors for the Quarter and Half year ended · 12 Nov 2026
- Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended from time .... · 12 Nov 2026
- Pursuant to Part A of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio recording of Conference Call for Analysts and Investors held on November .... · 06 Nov 2026
- Symbiotec Signs 10 Year take or Pay Agreement to Manufacture Fermentation based alternative protein for EU Innovator · 06 Nov 2026
- The Monitoring Agency report issued by the CARE Edge Ratings, Monitoring Agency, appointed by the Company for the utilisation and application of funds raised through the IPO of the Company .... · 06 Nov 2026
- The Investor release being issued by the company, for the quarter and half year ended September 30, 2026 · 06 Nov 2026
- Pursuant to regulations 30 of the SEBI Listing Regulations, Investor Presentation on the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026. · 06 Nov 2026
- Symbiotec Pharmalab Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 06 Nov 2026
